TrialAnnals of oncology : official journal of the European Society for Medical Oncology2009

Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer.

P C Enzinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.